Cargando…

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

BACKGROUND: Adult T-cell leukemia lymphoma (ATLL) is a chemotherapy-resistant malignancy with a median survival of less than one year that will afflict between one hundred thousand and one million individuals worldwide who are currently infected with human T-cell leukemia virus type 1. Recurrent som...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauch, Daniel A., Olson, Sydney L., Harding, John C., Sundaramoorthi, Hemalatha, Kim, Youngsoo, Zhou, Tianyuan, MacLeod, A. Robert, Challen, Grant, Ratner, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456374/ https://www.ncbi.nlm.nih.gov/pubmed/32859220 http://dx.doi.org/10.1186/s12977-020-00535-z

Ejemplares similares

Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy
por: Poondru, Sneha, et al.
Publicado: (2022)

Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
por: Rauch, Daniel A., et al.
Publicado: (2021)

Tet-inducible lymphoma in a new Tax transgenic mouse model
por: Rauch, Daniel, et al.
Publicado: (2011)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016)

Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment
por: Ratner, Lee
Publicado: (2019)

Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF
por: Cheng, Xiaogang, et al.
Publicado: (2021)

Human T Cell Leukemia Virus Reactivation with Progression of Adult T-Cell Leukemia-Lymphoma
por: Ratner, Lee, et al.
Publicado: (2009)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models
por: Kim, Youngsoo, et al.
Publicado: (2019)

IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity
por: Rauch, Daniel A, et al.
Publicado: (2014)

IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity
por: Rauch, Daniel A., et al.
Publicado: (2014)

Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma
por: Baydoun, Hicham H, et al.
Publicado: (2015)

The mitigating effect of repeated memory reactivations on forgetting
por: MacLeod, Sydney, et al.
Publicado: (2018)

Interferons and Interferon Regulatory Factors in Malaria
por: Gun, Sin Yee, et al.
Publicado: (2014)

Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
por: Street, Shayna E.A., et al.
Publicado: (2002)

Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2015)

NKL homeobox gene activities in B-cell development and lymphomas
por: Nagel, Stefan, et al.
Publicado: (2018)

The effects of XMRV gene expression on the mouse prostate
por: Rauch, Daniel, et al.
Publicado: (2011)

IL-15 deficiency promotes tumor growth in tax transgenic mice
por: Rauch, Daniel, et al.
Publicado: (2011)

Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers?
por: MacLeod, Clare, et al.
Publicado: (2021)

Regulatory Functions of Interferons
por: Moore, M.
Publicado: (1981)

Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2018)

Interferons in hematopoiesis and leukemia
por: Schürch, Christian M, et al.
Publicado: (2013)

Absence of evidence or evidence of absence: reflecting on therapeutic implementations of attentional bias modification
por: Clarke, Patrick JF, et al.
Publicado: (2014)

Deregulated expression of NKL homeobox genes in T-cell lymphomas
por: Nagel, Stefan, et al.
Publicado: (2019)

Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2021)

Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia
por: Shukla, Vipul, et al.
Publicado: (2016)

SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines
por: Quentmeier, Hilmar, et al.
Publicado: (2009)

NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2018)

Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia
por: Emole, Josephine, et al.
Publicado: (2023)

The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia
por: Nagel, Stefan, et al.
Publicado: (2022)

Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia
por: Nagel, Stefan, et al.
Publicado: (2016)

Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus
por: Zhang, Y, et al.
Publicado: (2009)

Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2015)

The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease
por: MacLeod, Ruth, et al.
Publicado: (2015)

Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia
por: Nagel, Stefan, et al.
Publicado: (2020)

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
por: Orlova, Anna, et al.
Publicado: (2017)

Recent Advances in Therapeutic Approaches for Adult T-cell Leukemia/Lymphoma
por: Kato, Koji, et al.
Publicado: (2015)

Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia
por: Nagel, Stefan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b2jt9fs7nrldfmci73pgid3dds